Excimer Laser With Topical Agents in Psoriasis Vulgaris
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Psoriasis is a chronic, immune-mediated disease that affects approximately 2% of the
population. The development and exacerbation of psoriasis involve an interaction between
multiple genetic and environmental risk factors.